MarketPeel
Pricing
…
AS

Andrew J. Schwab

IDYA
10% OWNER · IDEAYA BIOSCIENCES, INC. · CIK 0001598549
FILING MIX · LIFETIME33%/67%
BUYS
42
SELLS
84
TOTAL VALUE
$186.96M
COMPANIES
10
ACTIVE SINCE
May 2020
HOLDINGS NOW
22,714,806
AVG SELL PX
$13.63
TRADE KIND
SHOWING 126 / 126
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
44 backtested trades · 8 horizons · 10 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Andrew J. Schwab, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d44+59.09%-1.84%+0.62%-2.46%-0.52%-1.42
14d44+59.09%-5.34%+0.81%-6.15%-6.76%-2.50
30d44+77.27%-11.80%+1.65%-13.44%-13.21%-6.12
60d44+68.18%-10.99%+4.70%-15.68%-21.70%-4.96
90d44+68.18%-8.81%+6.88%-15.68%-23.90%-3.38
180d44+52.27%-6.19%+12.20%-18.39%-30.03%-2.77
1y44(1 pending)+55.81%-22.97%+22.85%-45.82%-43.02%-5.40
2y44(9 pending)+54.29%-30.57%+26.17%-56.75%-43.78%-5.62
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IDYA · 384,496 shares · as of Nov 11, 2020
0546,8571,093,7141,640,5712,187,428SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 42 buys / 84 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CAMP
CAMP4 THERAPEUTICS CORP
SALE
32,018$4.50$144.1K2,433,280Aug 21, 2026Aug 21, 2026 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
46$0.32$1555,208Aug 20, 2026Aug 20, 2026 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
1,159$0.32$3711,400,560Aug 20, 2026Aug 20, 2026 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
6,495$0.32$2.1K7,850,155Aug 20, 2026Aug 20, 2026 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
SALE
114,700$4.54$520.7K2,465,298Aug 20, 2026Aug 21, 2026 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
10,255$0.35$3.6K1,401,719Aug 19, 2026Aug 20, 2026 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
409$0.35$14355,254Aug 19, 2026Aug 20, 2026 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
57,476$0.35$20.1K7,856,650Aug 19, 2026Aug 20, 2026 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
SALE
45,147$4.76$214.9K2,579,998Aug 19, 2026Aug 21, 2026 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
1,830$0.38$69555,663Aug 18, 2026Aug 20, 2026 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
253,080$0.38$96.2K7,914,126Aug 18, 2026Aug 20, 2026 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
45,090$0.38$17.1K1,411,974Aug 18, 2026Aug 20, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
52,317$6.85$358.4K2,783,781Aug 7, 2026Aug 10, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
10,494$7.00$73.5K2,836,098Aug 6, 2026Aug 10, 2026 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASEGRANT
Stock grant
3,179,558$1.53$4.86M3,179,558Aug 3, 2026Aug 5, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
1,718$6.85$11.8K2,846,592Jul 31, 2026Aug 3, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
114,756$6.93$795.3K2,848,310Jul 30, 2026Aug 3, 2026 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASEGRANT
Stock grant
28,000——28,000Jun 10, 2026Jun 12, 2026 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
75,000——75,000Mar 31, 2026Apr 2, 2026 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Feb 6, 2026Feb 9, 2026 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
200,000$8.80$1.76M2,963,066Nov 14, 2025Nov 18, 2025 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASEGRANT
Stock grant
2,941,176$1.53$4.50M2,941,176Sep 11, 2025Sep 15, 2025 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
6,470$3.42$22.1K57,493Aug 22, 2025Aug 22, 2025 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
163,979$3.42$560.8K1,457,064Aug 22, 2025Aug 22, 2025 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
58,642$3.57$209.4K1,621,043Aug 21, 2025Aug 22, 2025 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
2,314$3.57$8.3K63,963Aug 21, 2025Aug 22, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
6,935$7.50$52.0K1,093,313Jul 9, 2025Jul 11, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
20,065$7.50$150.5K3,163,066Jul 9, 2025Jul 11, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
18,578$7.12$132.3K3,183,131Jul 1, 2025Jul 1, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
6,422$7.12$45.7K1,100,248Jul 1, 2025Jul 1, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
18,578$6.81$126.6K3,201,709Jun 30, 2025Jul 1, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
6,422$6.81$43.8K1,106,670Jun 30, 2025Jul 1, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
55,735$6.91$385.1K3,220,287Jun 27, 2025Jul 1, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
19,265$6.91$133.1K1,113,092Jun 27, 2025Jul 1, 2025 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASEGRANT
Stock grant
9,000——9,000Jun 25, 2025Jun 27, 2025 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Feb 24, 2025Feb 26, 2025 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
70,000——70,000Oct 28, 2024Oct 30, 2024 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASE
909,090$11.00$10.00M2,625,145Oct 15, 2024Oct 15, 2024 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASE
302,770——302,770Oct 15, 2024Oct 15, 2024 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASE
378,463——1,716,055Oct 15, 2024Oct 15, 2024 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
SALE
3,395,816——0Oct 15, 2024Oct 15, 2024 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASE
1,337,592——1,337,592Oct 15, 2024Oct 15, 2024 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
SALE
4,244,770——0Oct 15, 2024Oct 15, 2024 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
SALE
15,002,166——0Oct 15, 2024Oct 15, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
11,758$6.06$71.3K8,167,206Sep 13, 2024Sep 13, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
79$6.06$47966,277Sep 13, 2024Sep 13, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
2,000$6.06$12.1K1,679,685Sep 13, 2024Sep 13, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
1,440$6.60$9.5K66,356Sep 11, 2024Sep 13, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
36,504$6.60$240.9K1,681,685Sep 11, 2024Sep 13, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
214,556$6.60$1.42M8,178,964Sep 11, 2024Sep 13, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
SALE
843,592——0Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
SALE
214,692——0Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
1,058,284——1,058,284Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
348,721$10.20$3.56M348,721Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
112,966$10.20$1.15M1,171,250Jul 22, 2024Jul 24, 2024 ↗View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
833,333$12.00$10.00M1,182,054Jul 22, 2024Jul 24, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
450,000$10.00$4.50M8,393,520Mar 13, 2024Mar 15, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Feb 29, 2024Mar 4, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
688,358$14.90$10.26M3,200,634Feb 14, 2024Feb 16, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
136,642$14.90$2.04M635,341Feb 14, 2024Feb 16, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
5,206,074$2.31$12.03M7,943,520Jan 31, 2024Feb 2, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
417,187$15.00$6.26M3,888,992Jan 31, 2024Feb 2, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
82,813$15.00$1.24M771,983Jan 31, 2024Feb 2, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
14,110——20,001Nov 6, 2023Nov 6, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
164,789$15.00$2.47M4,306,179Sep 26, 2023Sep 28, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
32,711$15.00$490.7K854,796Sep 26, 2023Sep 28, 2023 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
1,472,692——1,472,692Aug 25, 2023Aug 29, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
72,876$16.00$1.17M887,507Aug 24, 2023Aug 28, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
367,124$16.00$5.87M4,470,968Aug 24, 2023Aug 28, 2023 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
426,348,120——426,348,120Aug 18, 2023Aug 22, 2023 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
10,558,878——10,558,878Aug 18, 2023Aug 22, 2023 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
161,944,872$0.01$1.67M429,546,911Aug 18, 2023Aug 22, 2023 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
267,602,039——267,602,039Aug 18, 2023Aug 22, 2023 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
684,361,447$0.01$7.05M684,361,447Aug 18, 2023Aug 22, 2023 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASEGRANT
Stock grant
6,389,921$0.01$65.8K16,948,799Aug 18, 2023Aug 22, 2023 ↗View →
RLYB
RALLYBIO CORP
SALE
100,000$8.20$820.0K2,378,969Mar 7, 2023Mar 9, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
27,567——27,567Feb 23, 2023Apr 6, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
960,383——960,383Feb 23, 2023Feb 27, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,838,092——4,838,092Feb 23, 2023Feb 27, 2023 ↗View →
RLYB
RALLYBIO CORP
SALE
99,671$12.50$1.25M2,478,969Jun 3, 2022Jun 7, 2022 ↗View →
RLYB
RALLYBIO CORP
SALE
50,329$12.50$629.1K1,251,755Jun 3, 2022Jun 7, 2022 ↗View →
RLYB
RALLYBIO CORP
SALE
66,447$13.00$863.8K2,578,640May 23, 2022May 25, 2022 ↗View →
RLYB
RALLYBIO CORP
SALE
33,553$13.00$436.2K1,302,084May 23, 2022May 25, 2022 ↗View →
RLYB
RALLYBIO CORP
SALE
70,461$13.05$919.5K1,335,637Feb 8, 2022Feb 10, 2022 ↗View →
RLYB
RALLYBIO CORP
SALE
139,539$13.05$1.82M2,645,087Feb 8, 2022Feb 10, 2022 ↗View →
VOR
VOR BIOPHARMA INC.
SALE
91,836$15.30$1.41M1,766,634Nov 16, 2021Nov 18, 2021 ↗View →
VOR
VOR BIOPHARMA INC.
SALE
238,870$15.30$3.65M4,595,089Nov 16, 2021Nov 18, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
2,371,739——3,021,510Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
318,616——649,771Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
254,512——3,276,022Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
564,217——564,217Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
318,140——882,357Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
250,000$20.00$5.00M1,132,357Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
2,305,473——0Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
1,841,620——0Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
17,161,644——0Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
2,302,026——0Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
4,082,613——0Nov 2, 2021Nov 4, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
258,456$13.00$3.36M1,731,119Nov 1, 2021Nov 3, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
36,544$13.00$475.1K333,144Nov 1, 2021Nov 3, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
625,000$9.70$6.06M1,989,575Sep 7, 2021Sep 9, 2021 ↗View →
RLYB
RALLYBIO CORP
PURCHASE
615,384$13.00$8.00M1,406,098Aug 2, 2021Aug 4, 2021 ↗View →
VOR
VOR BIOPHARMA INC.
PURCHASE
1,414,026——1,414,026Feb 9, 2021Feb 9, 2021 ↗View →
VOR
VOR BIOPHARMA INC.
PURCHASE
444,444$18.00$8.00M1,858,470Feb 9, 2021Feb 9, 2021 ↗View →
VOR
VOR BIOPHARMA INC.
PURCHASE
1,414,026——4,722,848Feb 9, 2021Feb 9, 2021 ↗View →
VOR
VOR BIOPHARMA INC.
PURCHASE
3,308,822——3,308,822Feb 9, 2021Feb 9, 2021 ↗View →
VOR
VOR BIOPHARMA INC.
PURCHASE
111,111$18.00$2.00M4,833,959Feb 9, 2021Feb 9, 2021 ↗View →
VOR
VOR BIOPHARMA INC.
SALE
19,230,768——0Feb 9, 2021Feb 9, 2021 ↗View →
VOR
VOR BIOPHARMA INC.
SALE
45,000,000——0Feb 9, 2021Feb 9, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
10,530$13.00$136.9K369,688Jan 12, 2021Jan 12, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
74,470$13.00$968.1K2,614,575Jan 12, 2021Jan 12, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
264,589$13.00$3.44M2,689,045Jan 8, 2021Jan 12, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
37,411$13.00$486.3K380,218Jan 8, 2021Jan 12, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
261,084$14.75$3.85M2,953,634Dec 10, 2020Dec 14, 2020 ↗View →
CABA
CABALETTA BIO, INC.
SALE
36,916$14.75$544.5K417,629Dec 10, 2020Dec 14, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
657,117$13.66$8.98M2,187,428Nov 11, 2020Nov 13, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
27,379$13.66$374.0K91,142Nov 11, 2020Nov 13, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
115,504$13.66$1.58M384,496Nov 11, 2020Nov 13, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
175,000$25.30$4.43M138,497Oct 5, 2020Oct 7, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
115,357$33.30$3.84M1,823,192Jun 16, 2020Jun 18, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
19,836$33.30$660.5K313,497Jun 16, 2020Jun 18, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
4,807$33.30$160.1K75,965Jun 16, 2020Jun 18, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
9,800$28.75$281.8K80,772Jun 11, 2020Jun 15, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
235,200$28.75$6.76M1,938,549Jun 11, 2020Jun 15, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
244,800$35.15$8.60M2,173,748May 19, 2020May 21, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
10,200$35.15$358.5K90,572May 19, 2020May 21, 2020 ↗View →
Other insiders · IDYA
Loading peer insiders…
About this filer
CIK 0001598549
ROLE
10% Owner
PRIMARY
IDYA
COMPANIES
10
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001598549DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback